GUANGZHOU, China, May 27, 2022--(BUSINESS WIRE)--LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Abstract Number：e16102 Abstract Title：Global multi-center phase I trial of the intraperitoneal infusion of anti-EpCAM x anti-CD3 bispecific antibody catumaxomab for advanced gastric carcinoma with peritoneal metastasis.

The abstract is about the cohort A, stage I of the ongoing global phase Ⅲ trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis (clinicaltrials.gov: NCT04222114). Worldwide, GC is one of the most common cancers, contributing to more than 1 million cases per year and 5.6% of all cancer diagnoses [1]. Approximately 50% of the advanced GC patients will develop peritoneal metastasis after radical resection, along with malignant ascites in most cases. Furthermore, peritoneal metastasis is associated with poor prognosis and quality of life compared with metastasis to other organs [2]. Peritoneal metastasis is treated with systemic therapies. The estimated survival period for the patients who fail to respond to third-line therapy is limited to only 2.3-2.4 months according to multiple RCTs.

In our study, 9 GC patients with peritoneal metastasis (33% had failed third-line therapy) were treated with Catumaxomab, the median overall survival was 3.4 months, with remarkable ascites regression. Catumaxomab as an T cell engaging immunotherapy has showed promising early efficacy signals.

About Catumaxomab Catumaxomab was approved by the European Medicines Agency in 2009 for the treatment of malignant ascites. It is a bispecific antibody that binds to EpCAM (the epithelial cell adhesion molecule) on the tumor cell--and CD3 on the T cell, recruits immune accessory cells through FcγR binding at the same time. Catumaxomab kills tumor cells by engaging T cell and accessory cell mediated cytotoxicity and has the potential to induce long-term vaccinal effects which has been verified in animal models. Currently, Catumaxomab is being evaluated in clinical trials for both advanced gastric cancer (NCT04222114) and non-muscle invasive bladder cancer (NCT04799847).

About LintonPharm LintonPharm Co., Ltd. is a clinical-stage, research-oriented biopharmaceutical company committed to developing innovative T cell engaging bispecific antibodies with the goal of turning malignant cancers into manageable and possibly curable diseases. LintonPharm has developed multiple bispecific antibody platforms with a great potential of refined safety and efficacy profiles, long-lasting vaccinal effects and CMC efficiency. The current pipeline includes several treatments in development for blood cancer and solid tumors. For more information, please visit www.lintonpharm.com

1. World Health Organization (WHO). Globocan 2020. Global Cancer Observatory. Accessed January 7, 2021. https://gco.iarc.fr/ 2. Jennifer L.L. & Travis E.G. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018 October 15; 10(10): 282-289.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220527005174/en/

Media Contacts: Mia He LintonPharm jingyi.he@lintonpharm.com

Global biopharmaceutical company Sanofi (NASDAQ: SNY) encountered setbacks while developing its COVID-19 vaccine, and only this year reported results from late-stage clinical trials. Sanofi opted for the more traditional protein-based technology for its COVID-19 vaccine, Vidprevtyn, rather than the mRNA technology of Pfizer-BioNTech's Comirnaty and Moderna's Spikevax. The mRNA technology delivers genetic code instructing the body's cells to make the protein, while the more traditional approach produces the protein in a lab before injecting it into the body.

(Bloomberg) -- The Bloor West Village Women’s Clinic in Toronto has had very few American patients, despite advertising its abortion services internationally. That may be about to change. Most Read from BloombergGermany Pushes for G-7 Reversal on Fossil Fuels in Climate BlowSupreme Court Overturns Roe, Transforming Abortion-Rights FightJustice Kavanaugh Says States May Not Bar Travel to Obtain an AbortionProtest Latest: Tear Gas Used in Arizona; Driver Hits ProtestersSorry Elon Musk. Hyundai Is

One shot that was tested targeted Omicron specifically, while another was modified to work against the strain and the original virus.

Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.

Omicron has led to subvariants called BA 4 and BA 5. The current dominant variant spreading COVID in the U.S. is BA.2.12.1. What is the future of coronavirus variants?

The talks have picked up pace and the two companies are scheduled to meet this week. The proposed takeover would be one of the largest of the year and would beef up Merck’s cancer-drug portfolio.

New York City is making the monkeypox vaccine available to more people as the amount of cases continues to increase in the U.S. Now, groups of at-risk men who have had multiple male sex partners, or anonymous sex in the past two weeks, are eligible to receive a dose. Dr. Celine Gounder, the editor-at-large for public health at Kaiser Health News and an infectious disease expert and epidemiologist at the NYU Grossman School of Medicine and Bellevue hospital, has more on what health officials are doing to combat the spread.

Is monkeypox a "public health emergency of international concern"? A WHO committee decision could come as early as Friday.

Much of the funding Congress earmarks for the NCI each year ultimately goes into very early-stage research.

Now that the Supreme Court has overturned Roe v Wade, many states like South Carolina are poised to soon curb abortion, greatly expanding the distance between clinics.

Is Pfizer stock a buy after the FDA signed off on its Covid vaccine for babies and toddlers? Is PFE stock a buy right now?

Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce its participation at the H.C. Wainwright Global Investment Conference from June 27 – 28, 2022 in New York.

The parents of a premature baby who passed away at a Boston hospital have filed a lawsuit after the infant’s remains got lost in the facility’s morgue.

In a historic reversal, the U.S. Supreme Court on June 24 confirmed the long-awaited suspicion that they were going to weigh in and overturn Roe v Wade. Roe v. Wade has been the landmark case for abortion rights since it was decided in 1973. The case was decided on a 7-2 vote, stating that women had the constitutional right to an abortion.

Jamestown Canyon virus has been detected in a pool of mosquitoes collected in Bay County.

President Joe Biden falsely suggested that the Supreme Court ruling Friday overturning Roe v. Wade made the U.S. an "outlier" among the developed world.

(Bloomberg) -- The US Supreme Court decision to end the constitutional right to abortion is setting up a legal fight in some key states where lawmakers plan to enact bans before gubernatorial and congressional elections later this year.Most Read from BloombergGermany Pushes for G-7 Reversal on Fossil Fuels in Climate BlowSupreme Court Overturns Roe, Transforming Abortion-Rights FightJustice Kavanaugh Says States May Not Bar Travel to Obtain an AbortionProtest Latest: Tear Gas Used in Arizona; Dr

The decision will also put pressure on President Biden to act to protect abortion rights.

Maria Shriver is speaking out in the wake of the overturning of Roe v. Wade. The 1973 decision, which ruled that the U.S. Constitution protected a pregnant person's right to an abortion, was overturned on Friday.

Kentucky recorded abortions at six facilities in 2020, according to a state report. Where were the procedures performed, and what types were the most common? Here’s the commonwealth’s data.